Zdroje

The blood in our bodies, just like any other major part of our health system, can be affected by diseases and disorders. Hematologists study blood and the conditions that affect it to better understand how to keep it healthy. Research into the nature of blood has allowed blood, platelet, and plasma transfusions to become a common part of the treatment process for ill and injured patients.

PPTA prepares policy documents (such as issue briefs, statements, backgrounds, and white papers) on a variety of policy topics that are relevant to protecting patient access and are important to the association and its members.

Magazine of the plasma protein therapeutics industry - Winter 2011

PPTA advocates for rational regulatory policy through active dialogue with regulatory authorities throughout the world. PPTA supports regulatory policies that help ensure the safety and quality of plasma protein therapies. Regulatory staff respond to policy documents and issues, as needed, and are actively engaged on issues ranging from the collection of source plasma through the manufacture of therapies that are administered to patients. As regulations may differ in various parts of the world, PPTA also works to promote harmonization among them, where beneficial.